{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Biofrontera Inc."},"Symbol":{"label":"Symbol","value":"BFRI"},"Address":{"label":"Address","value":"120 PRESIDENTIAL WAY,SUITE 330, WOBURN, Massachusetts, 01801, United States"},"Phone":{"label":"Phone","value":"+1 781 245-1325"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection."},"CompanyUrl":{"label":"Company Url","value":"https://www.biofrontera-us.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Hermann LÃ¼bbert","title":"Chairman & Chief Executive Officer"},{"name":"Jon Lyons","title":"Vice President-Scientific & Medical Affairs"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}